Rallying around graduate student parents From helping new parents to coordinating play dates and sharing information, MIT students who are parents are there for one another. AI is changing healthcare and Harvard Medical School is following suit The Harvard Medical School started offering a month-long introductory course on AI in healthcare for HST students—the first of its kind offered at a medical school. A new framework to efficiently screen drugs Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen. Three questions for Thomas Heldt: Leveraging insights to enable clinical outcomes Thomas Heldt, associate director of IMES, and a core faculty member, describes the impact of his research on clinical outcomes. Jane-Jane Chen: A model scientist who inspires the next generation A research scientist, and internationally recognized authority in the field of blood cell development, reflects on 45 years at MIT. Pagination First page « First Previous page Previous … Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 … Next page Next Last page Last »
Rallying around graduate student parents From helping new parents to coordinating play dates and sharing information, MIT students who are parents are there for one another.
AI is changing healthcare and Harvard Medical School is following suit The Harvard Medical School started offering a month-long introductory course on AI in healthcare for HST students—the first of its kind offered at a medical school.
A new framework to efficiently screen drugs Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
Three questions for Thomas Heldt: Leveraging insights to enable clinical outcomes Thomas Heldt, associate director of IMES, and a core faculty member, describes the impact of his research on clinical outcomes.
Jane-Jane Chen: A model scientist who inspires the next generation A research scientist, and internationally recognized authority in the field of blood cell development, reflects on 45 years at MIT.
